Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancer

Abstract Curated electronic health records offer valuable insights into real-world outcomes for patients with advanced tumors. We described real-world treatment effectiveness among patients with HR+/HER2- metastatic breast cancer (mBC) and metastatic triple-negative breast cancer (mTNBC) using Conce...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Natalia Sadetsky, Patricia Prince, Helen Latimer, Pooja Advani, Demetria Smith-Gaziani, Peter A. Kaufman, Yanina Natanzon, Aliki Taylor, Linda Nguyen, Nick Freemantle
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-01-01
Edice:	Scientific Reports
Témata:	Metastatic triple-negative BC HR+/HER2-BC Overall survival Progression-free survival Response rate Time to next treatment or death
On-line přístup:	https://doi.org/10.1038/s41598-025-33530-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!